Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Marketing Authorisation Holders of leuprorelin-containing depot products: need to strictly follow instructions for reconstitution and administration to reduce the risk of handling errors that may result in lack of efficacy
Important Safety Information from Marketing Authorisation Holders of Leuprorelin-containing depot products as approved by the HPRA